API Gefitinib CAS 184475-35-2

Description:

Gefitinib adhibetur cancer pulmonis cellulam non parvam tractare, quae in alias partes corporis diffusa cum quibusdam speciebus tumorum in hominibus est.Gefitinib eft in genere medicamenti inhibitores kinase vocati.Operatur claudendo actionem cuiusdam substantiae naturaliter occurrentis quae opus est ad cellulas cancri adiuvandas multiplicandas.

Contactus: Erica Zheng

Email: erica@zhuoerchem.com

Tel: +86 21 2097 0332

Mob: +86 177 1767 9251

Whatsapp: LXXXVI CLXXXVI 2503 (LX)XLIII (WeChat & Telegram & Line)

Skype: slhyzy

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio

Tractare dicitur cancer pulmonis gefitinib.

Specificatio:

Product Name	Gefitinib
Nomen chemicum	N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine Gefitinib
Alia Nomen	N-(3-Chlor-4-fluorophenyl) -7-[methoxy-6-[(3-morpholin-4-yl)propoxyl]-quinazolin-4-yl]amine; -7Chemicalbook-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;IRESSA;GEFITINIB;n-(3-chloro-4-fluoro-phenyl)-7-methoxy-6 -(3-morpholin-4-ylpropoxy)quinazolin-4-amine
CAS Number	184475-35-2
Formulae hypotheticae	C22H24ClFN4O3
Formula Pondus	446.9
Aspectus	Pulvis albus
Assay	99.0% min
Liquescens punctum	119-120 °C
Ferveret	586.8±50.0 °C
Density	1.322±0.06 g/cm3
sarcina	20kg/peram/orum, 25kg/peram/orum, vel quod requiris
Repono	Repone continens arcte clausus in loco sicco & frigido.Non exponere solis dirigere.
COA & MSDS	Praesto
Applicationem	Ad investigationes propositum